Cyberkinetics Neurotechnology Systems, Inc.

Cyberkinetics Neurotechnology Systems, Inc. (Cyberkinetics) is a medical device company engaged in developing products for the treatment of neurological diseases, and injuries related to the spinal cord and peripheral nerves. BrainGate Neural Interface is currently the subject of a pilot clinical trial being conducted under an Investigational Device Exemption(IDE) by the Food and Drug Administration (FDA). The system is designed to restore functionality for a limited, immobile group of severely motor-impaired individuals. It is expected that people using the BrainGate System will employ a personal computer as the gateway to a range of self-directed activities. The company operates in the United States, Canada, Israel and Europe. It is headquartered in Massachusetts, the US.

Street: 
Suite 240
City: 
Foxborough
Postcode: 
02035
Federal State : 
United States
WebSite: 
www.cyberkineticsinc.com
Fax: 
1-508-5499985

Company Index Score

Current Index Score Historical Index Score
  • Cyberkinetics Neurotechnology Systems, Inc. currently scores 50 % in the index.
  • Cyberkinetics Neurotechnology Systems, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Cyberkinetics Neurotechnology Systems, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets